Bachem AG and Ardana plc today announced the conclusion of a long-term supply agreement for Aviptadil, an active constituent of Ardana’s Invicorp®. Invicorp®, which also contains the active ingredient phentolamine mesilate, is an intracavernous injectable drug combination for the treatment of male erectile dysfunction and has received marketing approval in Denmark, where it was launched before the end of 2006. Market entry in other European countries is envisaged for 2007.

Press Release